🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective study. It enrolls subjects with allergic rhinitis, wi...
Status
Not Yet Recruiting
Location
Huiying Wang
Start Date
2025-08
Trial ID
NCT07114107
Purpose: To evaluate the efficiency of Irritable Bowel Syndrome (IBS) pati...
Status
Completed
Location
UZ Antwerpen
Start Date
2013-11
Trial ID
NCT01908465
Purpose: To evaluate the efficiency of Irritable Bowel Syndrome (IBS) pati...
Status
Completed
Location
University hospitals Leuven
Start Date
2009-10
Trial ID
NCT01144832
Treatments Being Tested
This is an open-label phase I/II study evaluating the addition of ebastine ...
Status
Recruiting
Location
Department of Oncology 5073, Rigshospitalet
Start Date
2024-06-20
Trial ID
NCT06480110
Treatments Being Tested
A Prospective Clinical Study on the Efficacy and Safety of Bacterial Lysate...
Status
Not Yet Recruiting
Location
The Fourth Affiliated Hospital Zhejiang University School of Medicine
Start Date
2026-05-01
Trial ID
NCT07557888
Multicenter randomized controlled clinical trial comparing ebastine and meb...
Status
Recruiting
Location
GZA
Start Date
2023-03-30
Trial ID
NCT05815602
Treatments Being Tested
The antihistamines with inhaled steroids are the cornerstone on the symptom...
Status
Completed
Location
Medellin
Start Date
2013-08
Trial ID
NCT01940393
Treatments Being Tested
The goal of this clinical trial is to assess and compare the effect of ebas...
Status
Recruiting
Location
Dhaka Medical College
Start Date
2025-08-15
Trial ID
NCT07114055
To determine whether ebastine/pseudoephedrine is effective on subacute coug...
Status
Unknown
Location
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul Metropolitan Government, Seoul National University Boramae Medical Center
Start Date
2011-09
Trial ID
NCT02065440
Treatments Being Tested
This study evaluates ebastine, an FAK (focal adhesion kinase) inhibitor, as...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10-01
Trial ID
NCT07734766
Treatments Being Tested